NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia

OBJECTIVE: The aim of the study was to investigate whether nucleophosmin type A mutation (NPM1A) in plasma was associated with the prognosis of patients with acute myeloid leukemia (AML). METHODS: Plasma NPM1A levels were investigated in 80 AML patients, 22 patients with benign hematopathy and 12 he...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Open Life Sci
Prif Awduron: Sun, Chengming, Gao, Yujie, Yang, Liping, Shao, Huiyuan, li, Jie, Gao, Xuejun, Ma, Li, Lin, Mingming, Sui, Jingrui
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: De Gruyter 2018
Pynciau:
Topical Issue on Precision Medicine
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7874735/
https://ncbi.nlm.nih.gov/pubmed/33817088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/biol-2018-0028
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg